Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(50.0%)
Phase 3
1(50.0%)
2Total
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05957146Completed

Kinetics of Extracellular Vesicles in Hemodialysis

Role: collaborator

NCT00950573Completed

Arterial Calcifications in Nocturnal Hemodialysis and Renal Transplantation Versus Conventional Dialysis

Role: lead

NCT01276834Phase 4Terminated

Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal Transplantation

Role: lead

NCT00150956Phase 3Completed

Effects of Daily Home Hemodialysis on Circulation, Mental Functions, and Quality of Life

Role: collaborator

All 4 trials loaded